Stany Zjednoczone - angielski - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 4 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies ( 14.1) ]. glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to:  - glimepiride or any of the product’s ingredients [see warnings and precautions ( 5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives.   reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g. anaphylaxis, angioedema,

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

dr. reddy's laboratories limited - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 1 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ]. limitations of use glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to:  - glimepiride or any of the product’s ingredients [see warnings and precautions (5.2) ]. - sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives.   risk summary available data from a small number of published studies and postmarketing experience with glimepiride use in pregnancy over decades have not identified any drug associated risks for major birth defects, miscarria

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

blenheim pharmacal, inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies ( 14.1) ]. glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to:  - glimepiride or any of the product’s ingredients [see warnings and precautions ( 5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives.   reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g. anaphylaxis, angioedema,

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 4 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ]. glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to:  - glimepiride or any of the product’s ingredients [see warnings and precautions (5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives.   reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g. anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precautions (5.2) and adverse reaction

Malta - angielski - Medicines Authority

alfred e. tiefembacher (gmbh &co. kg) - vildagliptin; metformin hydrochloride - film-coated tablet - vildagliptin 50 mg; metformin hydrochloride 850 mg - drugs used in diabetes

Malta - angielski - Medicines Authority

alfred e. tiefembacher (gmbh &co. kg) - vildagliptin; metformin hydrochloride - film-coated tablet - vildagliptin 50 mg; metformin hydrochloride 1000 mg - drugs used in diabetes

Kanada - angielski - Health Canada

apotex inc - metformin hydrochloride - tablet (extended-release) - 500mg - metformin hydrochloride 500mg - biguanides

Kanada - angielski - Health Canada

apotex inc - metformin hydrochloride - tablet (extended-release) - 1000mg - metformin hydrochloride 1000mg - biguanides

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

bionpharma inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 1 mg - glimepiride tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ]. glimepiride tablets usp should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to: -  glimepiride or any of the product’s ingredients [see warnings and precautions (5.2)]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g., anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precautions (5.2) and adverse rea

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

proficient rx lp - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 1 mg - glimepiride tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies ( 14.1)]. glimepiride tablets usp should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablet is contraindicated in patients with a history of a hypersensitivity reaction to: sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g. anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precautions ( 5.2) and adverse reactions ( 6.2